Vaccines are biological preparations that contain agents resembling disease causing microorganisms, and can improve immunity against a specific disease. They are typically prepared from inactivated or weakened forms of the microbe or its toxins, or surface proteins. Classical vaccines against the influenza virus are developed in embryonated hen eggs and may include whole virus, split virus or a purified subunit with every component other than hemagglutinin (HA) or neuraminidase (NA) removed. The target molecule for the protective immune response triggered by vaccination is generally accepted to be the HA molecule; a glycoprotein found on the surface of the influenza virus. Measuring the vaccine potency or the biologically active components is critical to the determination of the vaccine's effective dose. In addition, the stability of the vaccine has major impact on its usage for immunization programs worldwide. Although real-time stability studies under different storage conditions is preferable, thermal stability testing using potency assays with samples subjected to heat or environmental stress conditions can be used as predicators of vaccine stability over time.
The Octet platform includes instruments, biosensors, reagents and assay kits for analysis of biomolecular interactions in 96- and 384-well microplates. Octet systems enable real-time, label-free analysis for determination of affinity, kinetics and concentration. Significantly easier, faster and better characterization of drug candidates is possible, providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost.
For more information, just fill out the form to download our application note.